MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
*Portfolio Companies: US Venture
Atricure, Inc (NASDAQ: ATRC)
Finance & Acquisitions: Atricure
ESTECH-Endoscopic Technologies
Parents
*Architects: Surgical Technology _ Cardiovascular, Cardiac & Cardiology Companies
*Architects: Surgical Technology_Catheters
*Architects: Surgical Technology_Endoscopes & Laproscopes
*Architects: Surgical Technology_Minimally Invasive & Natural Orifice Transluminal Endoscopic Surgery (NOTES) Technology
*Industry: California
*Industry: Northern California & Silicon Valley
*Portfolio Companies: Psilos
Companies: Acquired_(M&A)
Finance & Acquisitions: Atricure
Children
2013: AtriCure Inc Acquires California Company ESTECH for $34 million (2013)
Endoscopic Technologies is creating less invasive products to allow surgeons to access and manipulate the heart and perform cardiac procedures without open-heart surgery.
Investors participating in the financing include Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures and Tullis Health Investors.
June 2, 2009: Estech Completes Additional $8 Million Financing; Names Tony Remington as US Vice President of Sales
October 4, 2010: Estech Launches the COBRA Revolution™ Bipolar Clamp for Surgical Ablation
Over the last two years, Estech has raised over $28 million in equity financing to fund its innovation and business development strategies (2010)
San Ramon, California
Series D $8.5M by OnBioVC (2010)
The market potential for a truly minimally invasive, closed chest, reproducible ablation procedure to treat permanent and persistent atrial fibrillation, the most common type of abnormal heart rhythm, is estimated at over $2 billion worldwide.